Combination of palbociclib with adjuvant endocrine therapy for treatment of hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer: An experience at two cancer centers in Saudi Arabia

Autor:	Meteb Al‑Foheidi, Asem Albeshri, Safwan Moamenkahan, Abdulmajid Abdullah, Muhannad Abualola, Muath Alharbi, Ahmed Refa, Ali Bayer, Ahmed Shaheen, Syed Aga, Muhammad Khan, Mubarak Al‑Mansour, Ezzeldin Ibrahim
Rok vydání:	2021
Předmět:	Cancer Research Oncology
Zdroj:	Molecular and clinical oncology. 17(1)
ISSN:	2049-9469
Popis:	The addition of palbociclib (a cyclin-dependent kinase 4/6 inhibitor) to endocrine therapy (ET) has been shown to significantly improve progression-free survival (PFS) and overall survival (OS) among patients with hormone receptor-positive (HR
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed0d1d435f1071aaaca12031ed1c2d33 https://pubmed.ncbi.nlm.nih.gov/35747598 Zobrazit plný text záznamu